{"id":"W4408838287","doi":"10.51731/cjht.2025.1102","title":"Enfortumab Vedotin (Padcev)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Chemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002342138,0.00008975041,0.0003550411,0.0006605766,0.0001314439,0.0000162971,0.0001281064,0.00008856555,0.00003830408],"category_scores_gemma":[0.0002593785,0.00007018282,0.00008995418,0.0003173936,0.0001117874,0.00003695503,0.00001074975,0.0002681867,0.000005849267],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000895825,"about_ca_system_score_gemma":0.006519628,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00798013,"about_ca_topic_score_gemma":0.006722648,"domain_scores_codex":[0.9990895,0.00001273355,0.0004120126,0.00009084271,0.00008954047,0.0003053948],"domain_scores_gemma":[0.9993687,0.0000363154,0.0001824363,0.0002073759,0.0001204818,0.00008474817],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001748173,0.00003580713,0.05633454,0.0001198825,0.000100601,0.000259301,0.00007407499,0.000002937657,0.000005160245,0.004684273,0.04197926,0.8963867],"study_design_scores_gemma":[0.001408201,0.0007901522,0.1126311,0.001150946,0.00006243691,0.0002902719,0.001642735,0.000004009785,0.001220065,0.003456863,0.8772597,0.00008353775],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2643897,0.3205765,0.0002756898,0.4069937,0.0014346,0.0006247829,0.00002525562,0.0001711831,0.005508549],"genre_scores_gemma":[0.9960328,0.001595649,0.0004560848,0.001653356,0.000009469455,0.000008332289,0.000001606766,0.000006107688,0.0002366443],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8963031,"threshold_uncertainty_score":0.9991125,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01983278152439356,"score_gpt":0.3184423812480797,"score_spread":0.2986095997236861,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}